Correlation between serum cystatin C level and elderly hypertensive patients combined coronary heart disease

Ying Wang1, Xianming Su2, Wei Zhang2

  • 1The Medicine School of Xi'an Jiaotong University Xi'an 710061, Shaanxi ; Department of Geriatric Cardiology, The Nuclear Industry 215 Hospital Xianyang 712000, Shaanxi.

Insights

Serum cystatin C levels correlate with blood pressure and coronary artery stenosis severity in elderly patients. Higher levels indicate more severe hypertension and coronary heart disease, suggesting cystatin C as a potential disease severity predictor.

Area of Science:

  • Cardiology
  • Nephrology
  • Geriatrics

Background:

  • Elderly hypertension and coronary heart disease (CHD) are significant health concerns.
  • Biomarkers are needed to assess disease severity in these patients.

Purpose of the Study:

  • To investigate the relationship between serum cystatin C levels and elderly patients with both hypertension and CHD.
  • To determine if serum cystatin C can predict disease severity.

Main Methods:

  • Serum cystatin C levels were measured in 500 patients with hypertension and CHD using immunoturbidimetry.
  • Correlations were analyzed between cystatin C levels, blood pressure, and coronary artery stenosis degree.

Main Results:

  • Serum cystatin C levels showed a strong positive correlation with both blood pressure and coronary artery stenosis severity.
  • Patients with both hypertension and CHD had significantly higher cystatin C levels compared to control groups.

Conclusions:

  • Serum cystatin C levels are closely linked to the severity of hypertension and coronary artery stenosis in elderly patients.
  • Serum cystatin C may serve as a valuable predictor for disease severity in elderly patients with hypertension and CHD.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
868
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
773
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
631
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
733